2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
241
Lymphoma
178
Lymphoma, Large B-Cell, Diffuse
172
Precursor Cell Lymphoblastic Leukemia-Lymphoma
88
Lymphoma, Follicular
79
Lymphoma, Non-Hodgkin
73
Burkitt Lymphoma
66
Multiple Myeloma
64
Leukemia
58
Hodgkin Disease
45
Lymphoma, Mantle-Cell
41
Neoplasms
35
Lymphoma, T-Cell, Peripheral
31
Lymphoma, B-Cell
30
Lymphoma, B-Cell, Marginal Zone
28
Lymphoma, Large-Cell, Anaplastic
26
Neoplasm Metastasis
25
Lymphoma, Large-Cell, Immunoblastic
24
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
22
Leukemia, Lymphocytic, Chronic, B-Cell
22
Neoplasms, Plasma Cell
21
Recurrence
20
Immunoblastic Lymphadenopathy
15
Dendritic Cell Sarcoma, Interdigitating
15
Lymphoma, T-Cell
14
Leukemia, Biphenotypic, Acute
10
Waldenstrom Macroglobulinemia
9
Blast Crisis
9
Primary Myelofibrosis
8
Myelodysplastic Syndromes
8
Interventions
radium Ra 223 dichloride
2
pembrolizumab
2
enzalutamide
2
abiraterone
2
Injections
2
Abiraterone Acetate
2
niraparib
1
efineptakin alfa
1
darolutamide
1
capivasertib
1
cabazitaxel
1
apalutamide
1
Solutions
1
Radium-223
1
Prednisone
1
Pluvicto
1
PSMA-11
1
Lutetium-177
1
Lutetium
1
Docetaxel
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metastatic Castration-resistant Prostate Cancer (mCRPC)
×
Prednisone
×
Clear all
NCT03903835
2025-04-09
ProBio
Karolinska Institutet
Phase 3
Recruiting
750 enrolled